Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 164

Results For "ABI"

3664 News Found

NATCO invests US$ 2 million in Cellogen Therapeutics
News | January 18, 2024

NATCO invests US$ 2 million in Cellogen Therapeutics

Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy


Taro announces merger agreement with Sun Pharma
News | January 18, 2024

Taro announces merger agreement with Sun Pharma

Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023


Torque Pharma reinvents healthcare dynamics with 'Better Together'
News | January 18, 2024

Torque Pharma reinvents healthcare dynamics with 'Better Together'

The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme


Venus Remedies eceives GMP certification from Libya
News | January 18, 2024

Venus Remedies eceives GMP certification from Libya

The certification underscores Venus Remedies Limited's adherence to stringent quality control measures


Alkem Labs reports 'fraudulent transfer' of Rs 52 Cr
Digitisation | January 17, 2024

Alkem Labs reports 'fraudulent transfer' of Rs 52 Cr

The company disclosed that several employees of a subsidiary had their business email addresses stolen


Agilent announces new ProteoAnalyzer system
News | January 17, 2024

Agilent announces new ProteoAnalyzer system

Automated parallel capillary electrophoresis system simplifies protein analysis


INVpack presents microdosing precision in pharma and nutritional packaging for India
News | January 16, 2024

INVpack presents microdosing precision in pharma and nutritional packaging for India

Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets


Lupin Life hosted Second Edition of Aptivate Champion Run for Kids
News | January 15, 2024

Lupin Life hosted Second Edition of Aptivate Champion Run for Kids

The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars


ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for  treatment of prostate cancer
Supply Chain | January 15, 2024

ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for treatment of prostate cancer

PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York